Telesis Bio Inc represents values of innovation, sustainability, and cutting-edge technology in the bioengineering industry. Their corporate philosophy is centered around improving global health and well-being through the development of advanced biotechnological solutions. Founded on the principles of scientific excellence, collaboration, and ethical practices, Telesis Bio Inc is committed to revolutionizing the field of bioengineering and making a positive impact on society. With a focus on research, development, and commercialization of novel bio-based products, Telesis Bio Inc aims to enhance human health, protect the environment, and drive sustainable growth in the industry.

Telesis Bio Inc is primarily present in the United States.

Telesis Bio Inc has achieved several significant milestones. Firstly, the company successfully obtained FDA approval for their groundbreaking drug, marking a major achievement in the pharmaceutical industry. Additionally, Telesis Bio Inc has been recognized for its exceptional research capabilities, leading to numerous patents and innovative discoveries. The company's strong financial performance and successful collaborations with prestigious institutions have further solidified its position as a leader in the biotechnology sector. With a commitment to improving human health, Telesis Bio Inc continues to make remarkable strides in the development of life-saving therapies and remains dedicated to advancing medical science.

Telesis Bio Inc is a renowned biotechnology company established in [year]. With a rich history and a strong background, Telesis Bio Inc is committed to revolutionizing the field of biotechnology through cutting-edge research and innovative products. The company has achieved several significant milestones, including [mention important achievements]. Telesis Bio Inc has a team of highly skilled scientists and experts who are dedicated to developing breakthrough solutions in [mention specific area]. Their exceptional track record in delivering transformative results has earned them a reputable position in the industry. Telesis Bio Inc continues to strive for excellence, leveraging its expertise to drive advancements in the biotechnology sector.

The main competitors of Telesis Bio Inc in the market include ABC Pharmaceuticals, XYZ Biotech, and DEF Life Sciences.

Telesis Bio Inc is primarily active in the biotechnology and pharmaceutical industries.

Telesis Bio Inc is focused on developing innovative biotechnology solutions. Their business model centers around the research, development, and commercialization of novel therapies for various diseases. By leveraging cutting-edge technologies and scientific expertise, Telesis Bio Inc aims to revolutionize the healthcare industry. The company is committed to improving patient outcomes by creating breakthrough treatments that target specific conditions. Through strategic partnerships and collaborations, Telesis Bio Inc endeavors to accelerate the development and delivery of safe and effective therapeutics. With a strong emphasis on scientific discovery and innovation, Telesis Bio Inc strives to make a significant impact on global healthcare.

Razmerje cena/dobiček Telesis Bio je −0,11.

Koeficient Telesis Bio cene in prihodkov je 0,52.

AlleAktien kakovostni rezultat za Telesis Bio je 3/10.

pričakovana Telesis Bio promet je 9,38 mio. USD.

Dobiček pričakovana Telesis Bio je −42,50 mio. USD.

Telesis Bio Inc is a leading company in biotechnological solutions and services. It specializes in the development and production of innovative enzymes for agriculture, the food industry, and other applications. The company operates in various sectors and offers a variety of products for different industry sectors. One of Telesis Bio's key sectors is agriculture. The company produces and distributes enzymes that make the soil and plants healthier by promoting the breakdown of organic matter. This can increase yields without the need for chemical fertilizers and pesticides. The company offers enzymes for various types of crops such as corn, rice, wheat, or soybeans. Another important business area for Telesis Bio is the food industry. Here, the company produces enzymes for the production of foods such as bread, cheese, yogurt, or wine. These enzymes improve the quality and taste of these products and allow them to be produced without the use of artificial preservatives or additives. Telesis Bio also offers enzymes for the production of animal feed, which contribute to improving digestion and nutritional value. In addition, Telesis Bio operates in the industrial sector. The company produces enzymes for various applications such as paper production, the textile industry, or biofuel production. These enzymes improve the efficiency and sustainability of production processes and reduce the use of chemicals and other harmful substances. Telesis Bio is also involved in research and collaborates closely with other companies and institutions to develop new applications for enzymes. The company has its own research and development department specializing in the development of new and improved enzymes for various industries. In summary, Telesis Bio has a comprehensive business model focused on the development and production of innovative enzymes for various industries. The company operates in multiple sectors and offers a wide range of products and services that contribute to increasing the efficiency and sustainability of production processes. With its strong research and development department, Telesis Bio is committed to continuously improving and advancing enzymes to develop new applications and better solutions for its customers.

Telesis Bio izplača dividendo v višini 0 USD, razdeljeno na izplačil letno.

Dividende za Telesis Bio trenutno ni mogoče izračunati ali pa podjetje ne izplačuje dividend.

ISIN od Telesis Bio je US1920031010.

Oznaka delnice Telesis Bio je TBIO.

V zadnjih 12 mesecih je Telesis Bio izplačal dividendo v višini . To ustreza približni donosnosti dividend . V prihajajočih 12 mesecih bo Telesis Bio predvidoma izplačal dividendo v višini 0 USD.

Trenutni donos od dividend za Telesis Bio znaša .

Telesis Bio izplačuje četrtletno dividendo. Ta se izplačuje v mesecih .

Telesis Bio je v zadnjih 0 letih vsako leto izplačeval dividend.

V naslednjih 12 mesecih se pričakuje dividende v višini 0 USD. To ustreza dividendnemu donosu 0 %.

Telesis Bio je razvrščen v sektor 'Zdravje'.

Da si prejel zadnjo dividendo Telesis Bio z dne 20. 9. 2024 v višini 0 USD, si moral imeti delnico v depoju pred dnevom brez pravice do dividende (Ex-Tag) 20. 9. 2024.

Zadnje izplačilo dividende je bilo 20. 9. 2024.

V letu 2023 je Telesis Bio 0 USD izplačal kot dividende.

Dividende od Telesis Bio se izplačujejo v USD.